Robert Ssekubugu
Overview
Explore the profile of Robert Ssekubugu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Epstein-Shuman A, Zhu X, Hunt J, Fernandez R, Rozek G, Redd A, et al.
J Infect Public Health
. 2025 Mar;
18(6):102722.
PMID: 40086141
Objective: Autoantibodies (AAbs) to interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1, have been associated with COVID-19 severity. Despite relatively low COVID-19 morbidity and mortality in East and...
2.
Mihalakakos E, Ssempijja V, Ribeiro R, Molina-Paris C, Katushabe G, Nalwadda J, et al.
Emerg Microbes Infect
. 2025 Feb;
14(1):2465315.
PMID: 39945753
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease endemic to many regions of Africa, the Middle East, Southeast Asia and the Balkans. Caused by the CCHF virus (CCHFV), CCHF has...
3.
Murphy E, Hoffman S, Ssempijja V, Nalugoda F, Chang L, Ssekubugu R, et al.
J Acquir Immune Defic Syndr
. 2025 Jan;
PMID: 39885625
Background: Preventing HIV infections among adolescents and young adults (AYA) is crucial for curtailing the epidemic. Oral pre-exposure prophylaxis (PrEP) is a highly effective prevention method increasingly available to this...
4.
Akullian A, Ssempijja V, Breidenbecker D, Bridenbecker D, Nalugoda F, Nakigozi G, et al.
medRxiv
. 2025 Jan;
PMID: 39830262
Background: Recent declines in HIV incidence among adolescent girls and young women (AGYW) in Africa are often attributed to the expansion of biomedical interventions such as antiretroviral therapy and voluntary...
5.
Kreniske P, Nalugoda F, Chen I, Parate N, Wei Y, Chang L, et al.
J Acquir Immune Defic Syndr
. 2025 Jan;
97(5):433-438.
PMID: 39792139
Background: In sub-Saharan Africa, pediatric and adult treatment programs have not met the needs of youth living with HIV (15-24 years), whose enrollment in antiretroviral treatment (ART) programs is much...
6.
Daama A, Nalugoda F, Kankaka E, Kasango A, Nantume B, Kigozi G, et al.
PLoS One
. 2024 Nov;
19(11):e0297240.
PMID: 39570929
Introduction: Voluntary medical male circumcision (VMMC) reduces the risk of heterosexual acquisition of HIV by 50%-60%. The Uganda Ministry of Health recommends abstinence of sex for 42 days after VMMC...
7.
Ssekubugu R, Ndyanabo A, Makumbi F, Ekstrom A, Beres L, Kigozi G, et al.
Glob Health Action
. 2024 Nov;
17(1):2419160.
PMID: 39529556
During the COVID-19 pandemic lockdown, we deployed a rapid, mobile phone-based survey to assess access and participation rates when using mobile phones to collect data on COVID-19 in Rakai, south-central...
8.
Young R, Ssekasanvu J, Kagaayi J, Ssekubugu R, Kigozi G, Reynolds S, et al.
J Acquir Immune Defic Syndr
. 2024 Oct;
98(2):150-160.
PMID: 39477824
Introduction: In Africa, migrants are more likely to be living with HIV and HIV viremic than nonmigrants, but less is known about HIV outcomes among nonmigrants living in households with...
9.
Martin M, Reynolds S, Foley B, Nalugoda F, Quinn T, Kemp S, et al.
medRxiv
. 2024 Oct;
PMID: 39417110
Background: Clinical studies have reported rising pre-treatment HIV drug resistance during antiretroviral treatment (ART) scale-up in Africa, but representative data are limited. We estimated population-level drug resistance trends during ART...
10.
Kim S, Kigozi G, Martin M, Galiwango R, Quinn T, Redd A, et al.
Virus Evol
. 2024 Oct;
10(1):veae065.
PMID: 39399152
There is limited data on human immunodeficiency virus (HIV) evolutionary trends in African populations. We evaluated changes in HIV viral diversity and genetic divergence in southern Uganda over a 24-year...